CY1124587T1 - Μεθοδος για την παρασκευη toy brivaracetam - Google Patents

Μεθοδος για την παρασκευη toy brivaracetam

Info

Publication number
CY1124587T1
CY1124587T1 CY20211100890T CY211100890T CY1124587T1 CY 1124587 T1 CY1124587 T1 CY 1124587T1 CY 20211100890 T CY20211100890 T CY 20211100890T CY 211100890 T CY211100890 T CY 211100890T CY 1124587 T1 CY1124587 T1 CY 1124587T1
Authority
CY
Cyprus
Prior art keywords
brivaracetam
preparation
relates
present
new process
Prior art date
Application number
CY20211100890T
Other languages
English (en)
Inventor
Thierry DEFRANCE
Jean SEPTAVAUX
Didier NUEL
Original Assignee
UCB Biopharma SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by UCB Biopharma SRL filed Critical UCB Biopharma SRL
Publication of CY1124587T1 publication Critical patent/CY1124587T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • C07D207/263—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms
    • C07D207/27—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pyrrole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Η παρούσα εφεύρεση αναφέρεται σε μία νέα μέθοδο για την παρασκευή του brivaracetam. (μπριβαρακετάμη) (Ib)
CY20211100890T 2015-11-03 2021-10-14 Μεθοδος για την παρασκευη toy brivaracetam CY1124587T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP15192760 2015-11-03
PCT/EP2016/075935 WO2017076738A1 (en) 2015-11-03 2016-10-27 Process for preparing brivaracetam

Publications (1)

Publication Number Publication Date
CY1124587T1 true CY1124587T1 (el) 2022-07-22

Family

ID=54476761

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20211100890T CY1124587T1 (el) 2015-11-03 2021-10-14 Μεθοδος για την παρασκευη toy brivaracetam

Country Status (13)

Country Link
US (1) US10421717B2 (el)
EP (1) EP3371150B1 (el)
CY (1) CY1124587T1 (el)
DK (1) DK3371150T3 (el)
ES (1) ES2893301T3 (el)
HR (1) HRP20211518T1 (el)
HU (1) HUE056380T2 (el)
LT (1) LT3371150T (el)
PL (1) PL3371150T3 (el)
PT (1) PT3371150T (el)
RS (1) RS62472B1 (el)
SI (1) SI3371150T1 (el)
WO (1) WO2017076738A1 (el)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016191435A1 (en) 2015-05-25 2016-12-01 Peng Wang Processes to produce brivaracetam
US20210163410A1 (en) * 2017-05-29 2021-06-03 Msn Laboratories Private Limited, R&D Center An improved process for the preparation of (2s)-2-[(4r)-2-oxo-4-propyltetrahydro-1h-pyrrol-1-yl] butanamide and its intermediates thereof
CN108101824B (zh) * 2018-02-13 2020-04-03 扬州奥锐特药业有限公司 一种高手性纯度内酰胺中间体及布瓦西坦的制备方法
CN108147988B (zh) * 2018-02-13 2020-10-02 扬州奥锐特药业有限公司 一种高手性纯度内酰胺化合物的制备方法
CN108101823A (zh) * 2018-02-13 2018-06-01 扬州奥锐特药业有限公司 一种高手性纯度内酰胺中间体及布瓦西坦的制备方法
CN111333563B (zh) * 2018-12-19 2023-11-07 上海科胜药物研发有限公司 一种布瓦西坦中间体的制备方法
CN111122736B (zh) * 2019-12-30 2021-03-12 北京鑫开元医药科技有限公司海南分公司 一种用于检测布瓦西坦中间体中对映异构体的方法
CN111187175A (zh) * 2020-01-08 2020-05-22 上海朴颐化学科技有限公司 一种利用微通道反应器氢化制备布瓦西坦的中间体的方法
LV15614A (lv) 2020-07-30 2022-02-20 Latvijas Organiskās Sintēzes Institūts 2-(2-okso-3-pirolin-1-il)acetamīdi kā pretkrampju līdzekļi
CN114394921A (zh) * 2022-02-22 2022-04-26 浙江九洲药业股份有限公司 一种高纯度布瓦西坦的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0004297D0 (en) 2000-02-23 2000-04-12 Ucb Sa 2-oxo-1 pyrrolidine derivatives process for preparing them and their uses
EP1667967B1 (en) 2003-09-24 2012-08-01 UCB Pharma, S.A. Process for preparing 2-oxo-1-pyrrolidine derivatives
EP2053040A1 (en) * 2007-10-26 2009-04-29 Chemo Ibérica, S.A. Pregabalin intermediates and process for preparing them and Pregabalin

Also Published As

Publication number Publication date
PT3371150T (pt) 2021-11-05
PL3371150T3 (pl) 2022-01-17
SI3371150T1 (sl) 2021-11-30
DK3371150T3 (en) 2021-11-15
HRP20211518T1 (hr) 2021-12-24
ES2893301T3 (es) 2022-02-08
HUE056380T2 (hu) 2022-02-28
WO2017076738A1 (en) 2017-05-11
RS62472B1 (sr) 2021-11-30
US20190119206A1 (en) 2019-04-25
US10421717B2 (en) 2019-09-24
EP3371150A1 (en) 2018-09-12
EP3371150B1 (en) 2021-08-18
LT3371150T (lt) 2021-11-25

Similar Documents

Publication Publication Date Title
CY1124587T1 (el) Μεθοδος για την παρασκευη toy brivaracetam
CY1123247T1 (el) Διεργασια για το χειρισμο του επιπεδου της περιεκτικοτητας σε γλυκανη μιας γλυκοπρωτεϊνης
CY1122454T1 (el) Στερεες δοσολογικες μορφες palbociclib
EA201791029A1 (ru) Антитела против интерлейкина-33 и их применение
EA201691610A1 (ru) Анти-jagged1 антитела и способы применения
EA201792612A1 (ru) 6-аминохинолин-3-карбонитрилы в качестве модуляторов cot
EA201790982A1 (ru) Синтез копанлисиба и его дигидрохлорида
DK3218396T3 (da) Fremgangsmåde til fremstilling af højaffinitets antistoffer
EA201890322A1 (ru) Новый вид тобамовируса
CY1122578T1 (el) Φαρμακευτικο σκευασμα το οποιο περιλαμβανει αντισωμα
EA202091259A1 (ru) Способ получения опикапона и его интермедиатов
MX2017011389A (es) Proceso para la preparacion de 3-cloro-2-vinilfenilsulfonatos.
BR112017002139A2 (pt) ?método para preparar um composto?
MX2023009431A (es) Metodo para crear un compuesto a base de mercurio, compuesto a base de mercurio, metodos de uso del compuesto a base de mercurio y usos del compuesto a base de mercurio.
EA201691203A1 (ru) Твёрдые формы тенофовира
EA201692246A1 (ru) Способ получения 2,6-диметилбензохинона
EA201491913A1 (ru) Синтез калебина-а и его биологически активных аналогов
BR112019002828A2 (pt) método de preparação de derivados de estireno substituído
MX2016016398A (es) Preparacion de piperidin-4-carbotioamida.
MX2016015623A (es) Proceso para la preparacion de derivados dihidroisoxazol.
PH12020550958A1 (en) Method for producing carbodiimides
MX2016016397A (es) Proceso para preparar 3-cloro-2-vinilfenol.
EA202191779A1 (ru) Способ получения антраниламидов
CL2016002925A1 (es) Procedimiento mejorado para preparar ácidos crotónicos sustituidos
CY1123685T1 (el) Μεθοδος πεγκυλιωσης